Literature DB >> 3307408

Marrow transplantation for malignant disease.

E D Thomas.   

Abstract

The results of high-dose chemoradiotherapy and marrow transplantation from an HLA-identical sibling for various stages and types of leukemia and lymphoma are summarized. It has been shown that marrow transplantation can be carried out successfully using partially matched family members or matched unrelated donors. Some of the complications of marrow transplantation are discussed.

Entities:  

Mesh：

Year:  1987        PMID： 3307408     DOI： 10.1097/00000441-198708000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  3 in total

1.  The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis.

Authors:  Francesca Lorentino; Myriam Labopin; Katharina Fleischhauer; Fabio Ciceri; Carlheinz R Mueller; Annalisa Ruggeri; Avichai Shimoni; Martin Bornhäuser; Andrea Bacigalupo; Zafer Gülbas; Yener Koc; William Arcese; Benedetto Bruno; Johanna Tischer; Didier Blaise; Giuseppe Messina; Dietrich W Beelen; Arnon Nagler; Mohamad Mohty
Journal:  Blood Adv       Date:  2017-04-21

2.  Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia.

Authors:  Francesca Lorentino; Myriam Labopin; Fabio Ciceri; Luca Vago; Katharina Fleischhauer; Boris Afanasyev; Nicolaus Kröger; Jan J Cornelissen; Montserrat Lovira; Ellen Meijer; Antonin Vitek; Ahmet Elmaagacli; Didier Blaise; Annalisa Ruggeri; Christian Chabannon; Arnon Nagler; Mohamad Mohty
Journal:  Leukemia       Date:  2020-05-14       Impact factor: 11.528

3.  Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow.

Authors:  T Schmeiser; M Wiesneth; D Bunjes; R Arnold; B Hertenstein; W Heit; E Kurrle
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.